Page last updated: 2024-09-04

evodiamine and Colitis Gravis

evodiamine has been researched along with Colitis Gravis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, YD; Han, B; Li, P; Liao, QF; Lin, L; Lin, YX; Tian, X; Wang, MX; Xie, ZY; Zhong, YP	1

Other Studies

1 other study(ies) available for evodiamine and Colitis Gravis

Article	Year
Evodiamine has therapeutic efficacy in ulcerative colitis by increasing Lactobacillus acidophilus levels and acetate production. Pharmacological research, 2020, Volume: 159 Topics: Acetates; Animals; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Fecal Microbiota Transplantation; Feces; Gastrointestinal Agents; Gastrointestinal Microbiome; Inflammation Mediators; Intestinal Mucosa; Lactobacillus acidophilus; Male; Metabolomics; Quinazolines; Rats, Sprague-Dawley; Ribotyping	2020

Article

Year

Evodiamine has therapeutic efficacy in ulcerative colitis by increasing Lactobacillus acidophilus levels and acetate production.

Pharmacological research, 2020, Volume: 159

Topics: Acetates; Animals; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Fecal Microbiota Transplantation; Feces; Gastrointestinal Agents; Gastrointestinal Microbiome; Inflammation Mediators; Intestinal Mucosa; Lactobacillus acidophilus; Male; Metabolomics; Quinazolines; Rats, Sprague-Dawley; Ribotyping

2020